Biogen Seeks FDA Approval For Its Once-Doomed Drug For Alzheimer’s

There is reasonable confidence with Biogen CEO Michel Vounatsos about getting the approval for the drugmaker’s experimental Alzheimer’s drug from the United States Food and Drug Administration. “We worked in full transparency with the regulator,” Vounatsos said in a television interview while also emphasizing that all of the data about the drug that the company…

Q3 Earnings Of Boeing Lower Than Market Expectations But Firm Backs 737 Max Return

While the revenues for the United States based aircraft maker Boeing beat market estimates, its earnings were lower than what the market was expecting for the third quarter of the year. There was however an increase in the value of the shares of the company following positive messaging about the possibility of the return of…

Call To Resolve Trade Tensions Given By International Monetary And Financial Committee

A call for the fast resolutions of the ongoing trade spats and tensions between countries and supporting of the process of bringing in reforms to the World Trade Organization was given by the International Monetary and Financial Committee (IMFC), the policy-setting body of the International Monetary Fund (IMF). Growth outlook is “highly uncertain and subject…